Founded by a team of experienced entrepreneurs, technologists, and neuroscientists, ni2o is a spinout of Oxford University and is building on the work of MIT's Mind Machine Project. The core focus of ni2o is the development of a revolutionary brain-computer interface (BCI) that addresses the most pressing and costly medical needs of a rapidly aging global population. Their goal is to provide a breakthrough, minimally invasive, and technologically superior treatment for neurodegenerative brain diseases and disorders such as Parkinson's and Alzheimer's.

The flagship product of ni2o is the KIWI implant, which connects digital technology with organic elements to decode the language of the brain. Unlike current deep brain stimulation treatments, the KIWI implant is minimally invasive, eliminating the need for extensive surgery and potential complications. With a mission to make brain health democratized, accessible, and affordable for everyone, ni2o aims to significantly reduce the costs of treatment while improving outcomes.

They believe their groundbreaking technology will benefit mankind for generations to come, as they strive to create a future where brain disorders are cured and human dignity is restored